All results
7 results for randomized multicenter open label phase iii study evaluate efficacy and safety
-
Clinical Trials
The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to…
-
Clinical Trials
The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and…
-
Clinical Trials
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…
-
Clinical Trials
This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, PK, preliminary antitumor…
-
Clinical Trials
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…
-
News, Stories & Blog
Part 2 of our “Year in Review” focuses on the hospitals, research institutes and centers that are part of the UF Health family: UF Health Cancer Center UF…